Barinthus Biotherapeutics (BRNS)

• Market cap: $51M
• 1 day: -5.3%
• 5 days: -3.85%
• 1 month: -13.79%
• 3 months: -3.1%
• 6 months: 30.21%
• Year to date: 0.81%
• 1 year: -13.79%
• 5 years: -91.13%
• 10 years: -91.13%
• Sector: Healthcare
• Industry: Biotechnology

About: Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Employees: 105